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Summary Introduction
The association of autosomal recessive phosphorylase Phosphorylase kinase (PhK; ATP:phosphorylase b phos-
kinase deﬁciency in liver of a 31/2-year-old female child photransferase; E.C.2.7.1.38) plays an essential role in
with mutations in the gene encoding the common part glycogen breakdown. It catalyses the activation of phos-
of the b subunit of phosphorylase kinase is reported. phorylase by phosphorylation. Activated phosphoryl-
The proband had a severe deﬁciency of phosphorylase ase, in turn, catalyses the liberation of glucose-1-phos-
kinase in liver, while the phosphorylase kinase activity phate from glycogen. PhK consists of four different
in erythrocytes was only slightly diminished. She had no subunits—a, b, g, and d—which assemble to form the
symptoms of muscle involvement. The complete coding holoenzyme (abgd)4 . The activity of the catalytic site–
sequences of the liver g subunit and of the b subunit of containing g subunit is modiﬁed by the phosphorylation
phosphorylase kinase of the proband were analyzed for state of the a and b subunits, whereas the d subunit,
the presence of mutations, by either reverse-transcribed which is a calmodulin, confers calcium sensitivity to the
PCR or SSCP analysis. Three deviations from the normal enzyme (for reviews, see Pickett-Gies and Walsh 1986;
sequence were found in the region encoding the common Heilmeyer 1991). From molecular biological studies and
part of the b subunit of phosphorylase kinase—namely, from isolation and characterization of isoenzymes of
a 1827GrA (W609X) transition, a 2309ArG (Y770C) PhK, it has become known that there are two separate
transition, and a deletion of nucleotides 2896–2911— genes encoding isoforms of the a subunit of PhK (Zan-
whereas no mutations were detected in the sequence der et al. 1988; Davidson et al. 1992), a single gene
encoding the liver g subunit of phosphorylase kinase. encoding several isoforms of the b subunit of PhK (Har-
The 1827GrA mutation and the deletion both result in mann et al. 1991), two genes that encode isoforms of
the formation of early stop codons. Investigation of the g subunit of PhK (Hanks 1989; Jones et al. 1990;
DNA showed that the deletion is caused by a splice- Maichele et al. 1996), and at least three genes encoding
acceptor site mutation (IVS30-1,grt). Family analysis re- the d subunit of PhK (Scambler et al. 1987).
vealed that the 1827GrA and IVS30-1,grt substitutions Tissue-speciﬁc expression has been described for the
are located on different parental chromosomes and that genes encoding the isoforms of the a and g subunits of
compound heterozygosity for these mutations segregates PhK, whereas no tissue speciﬁcity has yet been found
with the disease. The 2309ArG mutation was detected for the expression of the d subunit–encoding genes. It
in 2%–3% of the normal population. Thus, it is con- has been hypothesized that the d subunit of PhK may
cluded that the deﬁciency of phosphorylase kinase in be provided by each of the calmodulin-encoding genes
this proband is caused by compound heterozygosity for (Bender et al. 1988). Tissue-speciﬁc variation of amino
the 1827GrA and the IVS30-1,grt mutations and that acid areas of the b subunit of PhK is generated by differ-
the 2309ArGmutation is a polymorphism. This implies ential splicing of the product of a single gene (Harmann
that a defect in the sequence encoding the common part et al. 1991).
of the b subunit of phosphorylase kinase may present The isoforms of the subunits, which form the constit-
as liver phosphorylase kinase deﬁciency. uents of the muscle isoenzyme of PhK, have been called
‘‘muscle a’’ (aM), ‘‘muscle b,’’ ‘‘muscle g,’’ (gM), and
‘‘muscle d.’’ The gene encoding the aM subunit is located
on human chromosome Xq12-q13 (Francke et al. 1989),Received December 31, 1996; accepted for publication June 6,
the b subunit lies on human chromosome 16q12-q131997.
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Berger, unpublished data) consists of the liver a (aL) weakness. Serum analysis revealed elevated transami-
nases, LDH, and triglycerides. These ﬁndings were indic-subunit, which maps to human chromosome Xp22 (Da-
vidson et al. 1992), the b subunit, the testis or liver g ative of a glycogen-storage disease with a mild clinical
presentation. Measurement of the activity of de-(gTL) subunit, which is located on chromosome 16p11-
p12 (Whitmore et al. 1994), and a d subunit. The g branching enzyme (deﬁcient in glycogen-storage disease
type III) in erythrocytes yielded high values (table 1),subunit of the liver isoenzyme was initially called ‘‘PhK-
gT,’’ because its mRNA is highly abundant in testis tissue whereas the activity of PhK was slightly diminished but
well above the values found for patients with X-linked(Hanks 1989). The subunit has been renamed ‘‘gTL’’ as
a result of the ﬁnding that defects in the gene encoding liver PhK deﬁciency. Repeated measurement of PhK ac-
tivity in erythrocytes from a second blood samplethis isoform of the g subunit can cause autosomal reces-
sive deﬁciency of PhK in liver (Maichele et al. 1996). yielded a normal value (table 1).
Deﬁciency of PhK may be caused by a defect in each A liver biopsy showed storage of glycogen without
of the genes encoding the isoforms of the a, b, and g ﬁbrosis. Measurement of PhK in liver revealed a strongly
subunits of PhK (reviewed in van den Berg and Berger diminished activity of PhK (7% of the lowest control
1990). In line with the hypothesis that the d subunit can value) in liver of the proband (table 1). Because of the
be supplied by different genes, it is expected that a defect absence of muscle involvement, a muscle biopsy was not
in one of these genes will not lead to deﬁciency of PhK. consented to by the parents. It was concluded that the
The tissue-speciﬁc expression and the chromosomal patient suffered from glycogen-storage disease in the
location of the affected gene will be reﬂected in the phe- liver and that the disease was due to deﬁciency of liver
notype and the mode of inheritance of the consequent PhK. PhK activity in erythrocytes of the newborn sister
deﬁciency of PhK. Thus, on the basis of the tissues that was slightly diminished (table 1).
are involved and on the basis of the mode of inheritance
of the various forms of PhK deﬁciency, candidate genes Isolation of RNA and DNA
can be assigned. Total RNA was isolated from lymphocytes of the pa-
In this study, the genetic defect causing deﬁciency of tient, the parents, and a control, by use of TripureTM
PhK in liver of a young female patient was elucidated. (Boehringer Mannheim) according to the manufactur-
Likely candidates for this form of PhK deﬁciency are the er’s instructions. DNA was isolated from peripheral
gene encoding the gTL subunit of PhK (Maichele et al. blood lymphocytes of the patient, the parents, the sister,
1996) and the nonmuscle region of the gene encoding the brother, and 40 control persons, by established
the b subunit of PhK. Both these candidates are located methods. DNA of the newborn sister was isolated from
on autosomes and are expressed in liver but not in mus- cord blood by use of established methods.
cle. In the patient described here, no mutations were
detected in these two candidate sequences. Instead, two
Isolation of cDNA Clones Containing Sequencesmutations that lead to the formation of early stop co-
Encoding the b Subunit of PhKdons were detected in the region of the b gene, which is
A human liver cDNA library was constructed by clon-expressed in liver and in muscle. This is, to our knowl-
ing the liver cDNAs into the polylinker of a bacterio-edge, the ﬁrst patient described with a phenotype of liver
phage lambda vector (Lambda Zap; Stratagene) withPhK deﬁciency that is associated with mutations in the
EcoRI. The library was screened with a 32P-labeled bgene encoding the b subunit of PhK.
probe from rabbit skeletal muscle, bPhK-D1N (Kili-
mann et al. 1988), which was provided by Dr. M. W.Patients, Material, and Methods
Kilimann (Institut fu¨r Physiologische Chemie, Ruhr-Uni-
Case History versita¨t, Bochum). Five positive clones were isolated by
this method. The clone with the largest insert (PhKb12),The proband, a girl 31/2 years old at the time of muta-
was sequenced completely. Sequencing was performedtion analysis, was born after an uneventful pregnancy,
by use of SequenaseTM version 2.0 (US Biochemical) ac-as the third child of nonconsanguineous parents. The
cording to the manufacturer’s instructions. The selectedparents and the two elder siblings were healthy, and
cDNA clone consisted of 3,015 nt, of which nt 1–2040there was no history of metabolic liver disease in the
were highly similar to nt 1249–3279 of the b sequencefamily. Recently, a fourth, female child was born.
from rabbit skeletal muscle (Kilimann et al. 1988), withAt the age of 23 mo, the proband was referred to a
the exception of nt 1088–1178 of the human liverpaediatrician because of hepatomegaly. She had a his-
cDNA clone, which encoded the alternatively splicedtory of hypoglycemia after prolonged fasting. Clinical
nonmuscle region of the b subunit of PhK (Harmann etexamination showed a girl with a doll facies and a dis-
al. 1991). This cDNA sequence has been submitted totended abdomen, which were due to hepatomegaly. Her
the EMBL data bank and has accession numberlength was at the 10th percentile, and her weight was
at the 90th percentile. There was no hypotonia or muscle X84897.
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Table 1
Measurement of Activities of Debranching Enzyme and Phosphorylase Kinase in Erythrocytes and of
Phosphorylase Kinase in Liver of Proband
ACTIVITIES INa
Erythrocytesb
Debranching Enzyme Phosphorylase Kinase Liver Phosphorylase Kinase
(nmol/24 h/mg Hb) (nmol/min2/mg Hb) (nmol/min2/mg protein)
Proband 88, 76 4.2, 6.9 25
Newborn 3.7, 4.6
Controls 10–45 (n Å 40) 6–18 (n Å 30) 350–1050 (n Å 6)
X-linked PhK deﬁciency 0–2.7 (n Å 21)
a n Å Number of subjects on which range is based.
b Two numbers for a given entry denotes that measurements were taken from two different blood samples.
Reverse Transcriptase–PCR (RT-PCR) and Sequencing listed in table 2. The PCR products were sequenced as
described above, with HLB-20F, HLB-25F, and HLB-of the Coding Region of the Human gTL Subunit of PhK
30R used as sequencing primers.Approximately 5 mg of total RNA of the patient and
a control was transcribed to cDNA with oligo-dT as a SSCP Analysis of the Gene Encoding the Human ß
primer, by use of Moloney murine leukemia virus re- Subunit of PhK
verse transcriptase (Gibco BRL) according to the manu-
PCR ampliﬁcation of exons 1–14 and of the frag-facturer’s instructions. PCR ampliﬁcation was essen-
ments containing mutations was performed as describedtially as described by Saiki et al. (1988). A 1,413-nt
above, with primers based on the genomic sequence offragment was ampliﬁed by PCR using the primers CCT-
the b subunit (Wu¨llrich-Schmoll and Kilimann 1996).TCAGGATGACGCTG (87-102 of PhK-gT [Hanks
Nonradioactive detection of SSCPs was performed by1989]) and ATGGCTCCCTTCCACCC (complemen-
the PhastSystemTM (Pharmacia-Biotech). The PCR prod-tary to nt 1499–1483 of PhK-gT [Hanks 1989]) and
ucts were diluted 1:1 in a formamide loading bufferwas subcloned into the TA vector (Invitrogen). Several
(98% formamide, 2% glycerol, 0.05% bromophenolclones were sequenced by the AmpliCycleTM sequencing
blue, and 0.05% xylene cyanol) and were heated at 95Ckit (Perkin-Elmer) and sequence-derived primers, ac-
for 4 min. The samples were loaded onto 20% homoge-cording to the manufacturer’s instructions.
nous phastgels (Pharmacia-Biotech), and electrophoresis
was performed at 4C or 15C. Running time of theRT-PCR and Mutation Analysis of Part of the Coding
samples was determined by following the instructionsRegion of the b Subunit of PhK
of the manufacturer. DNA was visualized by silver
PCR ampliﬁcation of nt 79–2057 of the isolated staining.
cDNA sequence PhKb12 was as described by Saiki et
al. (1988), with the following primer pairs: (1) HLBF Analysis of Ampliﬁed Created Restriction Sites in
(GGGGACAAGCACTTTATATCATCG, nt 79–102 of Genomic DNA Fragments
the PhKb12 clone) and HLBR (TGTTTGCCCTGC- A 119-nt fragment was ampliﬁed from DNA of the
ACTAAAAC, complementary to nt 1177–1158 of the patient, her family, and a control, by primer HLB-20F
PhKb12 clone) and (2) HLBFA (ACCCACCCACGA- and primer HLB-20Rm with a single mismatch comple-
AATTCTTC, nt 917–936 of the PhKb12 clone) and mentary to nt 1829 of the coding sequence (table 2).
HLBRA (ACAGAGCTTCCTACACCTTC, comple- The fragments were digested with MboII. A 155-nt frag-
mentary to nt 2057–2038 of the PhKb12 clone). The ment was ampliﬁed from DNA of the patient, her family,
PCR products were sequenced directly as described and 40 controls, by primer HLB-25F and primer HLB-
above, by use of sequence-derived primers. 25Rm with a mismatch complementary to nt 2310 (table
2). The PCR products were digested with XbaI. A 147-
Sequencing of DNA Fragments nt fragment was ampliﬁed from DNA of the patient, her
family, and a control, with the primers HLB-31Fa andDNA of the patient, her family, and a control was
ampliﬁed as described above, by the following primer HLB-31Rm, which contain a mismatch complementary
to nt 2897 of the coding sequence (table 2). The PCRpairs: HLB-20F and HLB-20R, HLB-25F and HLB-
25Rm, and HLB-31F and HLB-31R. The primers are products were digested with AluI. The restriction
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Table 2
List of Primers Used for Ampliﬁcation of DNA Fragments from Gene Encoding b Subunit of PhK
Size
Oligonucleotide Exon Sequencea Positionb (bp)
HLB-20Rm AGTGGACGTCCATGCATTCT 1847 264
HLB-20F 20 ACTCATGGTTGAGCATCCTG 059 119
HLB-20R TCCACCACATACTAAGAAGG /112
HLB-25F 25 AACTCTAGTGAAGCACAGTG 0140 155
HLB-25Rm TTTGGCTGCCAGCTCTTCTC 2329
HLB-31F 31 TGAGAACCAGAGCATAACGG 053 215
HLB-31R TCACGGAGCAGAGAGAAGGC /54
HLB-31Fa 31 GCTGAAAATGTTCTCCAAGG 0127 147
HLB-31Rm ATATCTGACAGGGTTGGTAG 2915
a Nucleotides that are mutated to generate an ampliﬁed created restriction site in combination with either
the normal or mutated sequence are underlined.
b Derived from the PHKB-gene, GenBank/EMBL accession numbers X84909–X84938 (Wu¨llrich-Schmoll
and Kilimann 1996).
fragments were analyzed on a 6% polyacrylamide se- the patient contained three deviations from the normal
quencing gel without urea. The fragments were visual- sequence: (1) a GrA mutation at nt 500 of the ampliﬁed
ized by staining the gel with ethidium bromide for fragment, changing the codon for a tryptophan to a stop
10 min. codon (ﬁg. 1); (2) an ArG mutation at nt 982 of the
ampliﬁed fragment (not shown), which leads to substitu-
Sequence Notation tion of tyrosine by cysteine; and (3) a deletion compris-
The ﬁrst nucleotide of the coding sequence is deﬁned ing nt 1565–1580 or nt 1569–1584 of the ampliﬁed
as nt 1. The numbers of the nucleotides of the intron fragment (ﬁg. 2). The patient was heterozygous for each
sequences are either related to the g of the splice-donor of the three mutations.
site (/1) or to the g of the splice-acceptor site (01). The While these investigations were in progress, the com-
starting methionine of the coding sequence is deﬁned as plete genomic structure of the human gene encoding the
amino acid 1. b subunit of PhK was reported (Wu¨llrich-Schmoll and
Kilimann 1996). Comparison of the reported sequence
Results with the sequence of the PhKb12 clone showed that the
PhKb12 clone contained nt 1274–3306 of the (nonmus-The complete coding sequence of the gTL subunit of
cle) coding sequence and nt 3307–4277 of the 3 UTRPhK was ampliﬁed, by RT-PCR, from lymphocyte
of the human b mRNA. The mutations detected in themRNA of the patient, as described in Patients, Material,
b fragment of the patient were found to be a 1827GrAand Methods. The ampliﬁed product was cloned, and
(W609X) transition, a 2309ArG (Y770C) mutation,several independent clones were sequenced completely.
and a deletion either of nt 2892–2907 or of nt 2896–No deviations from the normal sequence were found in
2911 of the coding sequence of the b subunit. No dis-the coding region of the gTL subunit of the patient.
crimination can be made between these two possibilitiesSince no mutations could be detected in the sequence
by sequencing the cDNA, because a CTAG stretch bothencoding the gTL subunit of this patient, the second likely
precedes the deletion and forms the end of the deletioncandidate, which is the nonmuscle alternatively spliced
(ﬁg. 2B). However, since nt 2896–2911 are the ﬁrst 16region of the coding sequence of the b subunit of PhK,
nt of exon 31 and end with the splice-acceptor consensuswas analyzed for the presence of deviations from the
dinucleotide AG, it is highly probable that the deletioncontrol sequence. Part of the coding sequence of the b
in the mRNA of the patient is caused by a splice-acceptorsubunit of PhK was ampliﬁed from patient and control
site mutation in intron 30, resulting in the use of anlymphocyte mRNA by RT-PCR, by use of primer se-
alternative splice-acceptor site in exon 31. Thequences derived from the PhKb12 clone (see Patients,
1827GrA mutation may lead to the formation of a trun-Materials and Methods). The alternatively spliced non-
cated protein, which lacks 485 C-terminal amino acidsmuscle sequence corresponds to nt 1010–1100 of the
(ﬁg. 1B). Alternatively, the amount of the 1827GrAampliﬁed fragment. No mutation was detected in this
containing mRNA may be strongly diminished, because91-nt region of the b sequence of the proband. However,
of unstability of the mRNA. Translation of the mRNAon sequence analysis of the remaining part of this b
sequence, it was found that the ampliﬁcation product of harboring the 16-nt deletion may yield a truncated pro-
/ 9a35$$se08 08-25-97 18:29:33 ajhgal UC-AJHG
543van den Berg et al.: Defects in the Phosphorylase Kinase b Gene
by ampliﬁcation of exons 1–14 by PCR, from DNA
of the proband and a control, as described in Patients,
Material, and Methods, followed by SSCP analysis of
the ampliﬁed fragments. No deviations from the normal
electrophoresis pattern were detected in exons 1–14 of
the gene encoding the b subunit of PhK of the proband
(results not shown).
The DNA fragments harboring the respective muta-
tions identiﬁed in the coding region of the b subunit of
the proband were ampliﬁed from genomic DNA of the
proband, her parents, and a control and were sequenced
directly. The 1827GrA (W609X) transition was found
in DNA of the patient and in DNA of the father but not
in DNA of the mother (ﬁg. 1C). The proband and her
parents were all found to be heterozygous for the
2309ArG (Y770C) mutation (not shown). The conclu-
sion that the 16-nt deletion is caused by an acceptor-
splice site mutation was conﬁrmed by the detection of
a grt transversion at the downstream boundary of in-
tron 30 of the b gene (IVS30-1,grt), in the DNA frag-
ments of the proband and her mother but not in DNA
of the father (ﬁg. 2C). Each of the three mutations de-
scribed here was detectable by SSCP analysis (not
shown).
Primers were designed in order to create restriction
sites in combination with either the normal or the mu-
tated sequence. The 1827GrA (W609X) mutation is
detected by ampliﬁcation and digestion of a 119-nt
product surrounding the mutation. One mismatch
primer together with the mutation creates a restriction
site for MboII. The fragment harboring the mutation is
digested by MboII, whereas the fragment containing the
normal sequence remains undigested. The 2309ArG
(Y770C) mutation is detected by ampliﬁcation of a
155-nt DNA fragment surrounding the mutation, by a
mismatch primer that adds a XbaI restriction site to
Figure 1 Sequence analysis of part of the coding sequence of the normal sequence but not to the mutated sequence.
the b subunit of PhK harboring the 1827GrA (W609X) mutation. A, Treatment of the DNA fragments with XbaI results inPartial coding sequence of the b subunit of the proband (lanes P) and
digestion of the fragment containing the normal se-a control (lanes C), derived from cDNA. The cDNA was ampliﬁed as
quence but leaves the mutated fragment undigested. Thedescribed in Patients, Material, and Methods. The G’s of the two
sequences are applied to the gel in adjacent lanes. The same was IVS30-1,grt mutation is identiﬁed by ampliﬁcation of a
done for the A’s, T’s, and C’s. The proband is heterozygous for the 147-nt DNA fragment surrounding the mutation, by a
1827GrA (W609X) mutation (arrow). B, Inﬂuence of the 1827GrA mismatch primer that creates an AluI restriction site in(W609X) mutation on the amino acid sequence of the b subunit. The
the normal sequence but not in the mutated sequence.1827GrA (W609X) transition changes the codon for tryptophan to
Incubation with AluI results in digestion of the fragmenta stop codon (arrow). C, Partial coding sequence of the b subunit of
the proband (lanes P), her parents (lanes F [father] and lanes M containing the normal sequence, whereas the fragment
[mother]), and a control (lanes C), ampliﬁed from genomic DNA. The harboring the mutated sequence is not digested.
samples are applied to the gel as described under A. The father and Restriction analysis of the three respective DNA frag-the proband are heterozygous for the 1827GrA (W609X) mutation,
ments of the proband and her parents, by the appro-whereas the mother has the normal sequence.
priate restriction enzymes, yielded results that were in
agreement with the sequence data (ﬁg. 3). The newborn
sister of the proband was heterozygous for each of thetein of 966 amino acids, of which the C-terminal isoleu-
cine is introduced by the frameshift (ﬁg. 2B), or may three mutations and has, therefore, a genotype that, with
respect to the b gene of PhK, is identical to that in thelead to rapid breakdown of the resulting mRNA.
The 5 coding region of the b subunit of the proband proband (ﬁg. 3). An elder sister of the proband was
found to be heterozygous for the 1827GrA (W609X)was screened for the presence of additional mutations,
/ 9a35$$se08 08-25-97 18:29:33 ajhgal UC-AJHG
544 Am. J. Hum. Genet. 61:539–546, 1997
Figure 2 Sequence analysis of part of the coding sequence of the b subunit of PhK harboring the deletion of nt 2896–2911, and analysis
of the corresponding DNA sequence. A, Partial coding sequence of the b subunit of PhK derived from cDNA of the proband (lanes P) and a
control (lanes C). The complementary strand was sequenced. The samples are applied to the gel as described in ﬁgure 1. The starting point of
the deletion is indicated by the arrow. The starting 4 nt of the deletion are equal to the 4 nt ﬂanking the deletion, so that the exact location
of the deletion cannot be determined solely on the basis of analysis of the coding sequence of the b subunit. The deleted sequence is shown on
the right-hand side of the ﬁgure. B, Inﬂuence of the deletion of nt 2896–2911 on the amino acid sequence of the b subunit. The 4-nt repeat
is marked by a gray-shaded box. The extent of the deletion is indicated by the unbroken lines. Because of the frameshift, the glutamine is
substituted by an isoleucine (marked with an asterisk [*]), whereas the second codon turns into a stop codon (boxed). C, Partial sequence of
the b subunit of the proband (lanes P), her parents (lanes F [father] and lanes M [mother]), and a control (lanes C), derived from genomic
DNA. The samples are applied to the gel as described in ﬁgure 1. The complementary strand was sequenced. The mother and the proband are
both heterozygous for the IVS3001,grt mutation (arrow). D, Inﬂuence of the IVS3001,grt mutation on splicing. The nucleotides belonging to
the intron sequence are shown in lowercase letters, and the nucleotides of the coding sequence are shown in uppercase letters. A line above
the upper normal sequence indicates the normally spliced-out intron sequence. The sequence that is spliced out in the patient is underlined.
The IVS3001 nucleotide in patient DNA is surrounded by a box. The alternative splice-acceptor dinucleotide AG, which is utilized in patient
DNA, is denoted by a gray-shaded box.
transition, whereas the 2309ArG (Y770C) substitution Discussion
and the IVS30-1,grt splice-acceptor site mutation were
The proband presented here is a 31/2-year-old femalenot found in her DNA. Thus, she has inherited the
child who was found to suffer from an autosomal reces-1827GrA (W609X) mutation from her father, but not
sive form of PhK deﬁciency due to mutations in the genethe 2309ArG (Y770C) mutation. The only mutation
encoding the common part of the b subunit of PhK. Shedetected in DNA of the elder brother of the proband
has a severe deﬁciency of PhK in liver, whereas the activ-was the 2309ArG (Y770C) mutation, for which he was
ity of PhK in erythrocytes is only slightly diminished.heterozygous. These ﬁndings were conﬁrmed by either
Symptoms of muscle involvement are completely absent.sequencing or SSCP analysis (not shown). The mode of
A similar clinical presentation has been described forinheritance of the mutations in the family of the proband
the X-linked form of liver PhK deﬁciency, which isis illustrated in ﬁgure 4.
caused by mutations in the gene encoding the aL subunitTo investigate the distribution of the 2309ArG
of PhK, but association of this clinical phenotype with(Y770C) transition in the normal population, a 155-nt
mutations in the gene encoding the common part of theDNA fragment surrounding this mutation was ampliﬁed
b subunit of PhK has not been reported before.from DNA of 40 controls, by use of a mismatch primer
Initially, the gTL gene and the nonmuscle part of thethat adds a XbaI restriction site to the normal sequence,
b gene of PhK were considered to be the most likelyas described above. Both restriction analysis of the am-
candidate sequences, since both these regions are locatedpliﬁed fragments by XbaI and SSCP analysis showed
on autosomes and are expressed in liver but not in mus-that two of the normal controls were heterozygous for
cle. However, extensive investigations of the two above-the 2309ArG (Y770C) mutation, indicating that this
mentioned candidate sequences of the proband did notmutation may be found in 2%-3% of the normal popu-
lation. yield any positive results. In contrast, three mutations
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unstable mRNA, it is highly probable that these muta-
tions are disease-causing mutations.
Several additional lines of evidence indicate that the
1827GrA and IVS30-1,grt substitutions are responsible
for the PhK deﬁciency in this patient and that the
2309ArG (Y770C) mutation is a polymorphism. First,
family analysis shows that the 1827GrA (W609X) and
the IVS30-1,grt mutations are located on different chro-
mosomes of the patient (see ﬁg. 4). Second, the presence
of only one of these two mutations in members of the
family of the proband is associated with a normal phe-
notype. Third, the 1827GrA (W609X) transition and
the 2309ArG (Y770C) substitution are located on dif-
ferent chromosomes of the father, but he never experi-
enced any symptoms of liver disease, which implies that
one of these mutations is not disease causing. Finally,
the 2309ArG (Y770C) mutation is detected in 2%-3%
of the control population, and it is highly probable,
therefore, that this mutation is a polymorphism. Thus,
both on the basis of these arguments and on the basis
of the absence of mutations in the gene encoding the gTL
subunit of PhK, it is concluded that the proband suffers
from PhK deﬁciency due to compound heterozygosity
Figure 3 Analysis of DNA fragments that harbor the 1827GrA for a 1827GrA (W609X) transition and a IVS30-1,grt
(W609X), the 2309ArG (Y770C), and the IVS3001,grt mutations, am-
splice-acceptor site mutation in the gene encoding the bpliﬁed from DNA of the proband, her parents, the newborn sister, and
subunit of PhK. This implies that the newborn sister ofa control.A,MboII digestion of DNA fragments harboring the 1827GrA
(W609X) mutation. DNA of a control (lane 2), the father (lane 3), the the proband, who, with respect to the b gene, has the
mother (lane 4), the proband (lane 5), and the newborn (lane 6) was same genotype as the proband, will also be affected by
ampliﬁed as described in Patients, Material, and Methods. Digestion of the disease. This diagnosis is supported by the observa-
the ampliﬁed DNA fragment results in the formation of two fragments,
tion that the newborn sister has a slightly diminishedof 110 and 9 nt, when the mutation is present. The proband, her mother,
activity of PhK in erythrocytes (table 1) and has experi-and the newborn sister show a band of 119 nt (upper arrow), which is
the same length as that of the untreated PCR product (lane 1), and a enced an episode of hypoglycemia in the 2d mo after
band of 110 nt (lower arrow), indicating that they are heterozygous for birth.
the nonsense mutation. The control and the father are homozygous for The 1827GrA (W609X) and IVS30-1,grt mutations
the normal sequence. The band of 9 nt cannot be detected by this method.
will, theoretically, affect both the liver and the muscleB, XbaI digestion of DNA fragments harboring the 2309ArG (Y770C)
isoenzyme of PhK and are also expected to inﬂuencemutation. The samples are treated and applied to the gel, as described
above for panel A. Digestion of the ampliﬁed DNA fragment results in PhK activity in erythrocytes. However, the proband has
the formation of two fragments, of 132 and 23 nt, when the normal the clinical phenotype of liver PhK deﬁciency with only
sequence is present. The proband, her parents, and the newborn sister slightly diminished activity of PhK in erythrocytes. To
show a band of 155 nt (upper arrow), which is the same length as that
classify the phenotype associated with these mutations,of the untreated PCR product (lane 1), and a band of 132 nt (lower
measurement of the activity of the muscle isoenzyme isarrow), indicating that they are heterozygous for the missense mutation.
The control is homozygous for the normal sequence. The band of 23 nt needed. Unfortunately, muscle tissue was not available
cannot be detected by this method. C, AluI digestion of DNA fragments for measurement of PhK activity. The absence of symp-
harboring the IVS3001,grt mutation. The samples are treated and applied toms of muscle involvement in the proband does not
to the gel as described above for panel A. Digestion of the ampliﬁed
exclude deﬁcient activity of PhK in muscle, because mus-DNA fragment results in the formation of two fragments, of 126 and
cle symptoms may develop later in life, as has been re-20 nt, in the case of a normal sequence. The proband, her father, and
the newborn sister show a band of 146 nt (upper arrow), which is the ported for several patients suffering from isolated muscle
same length as that of the untreated PCR product, and a band of 126 PhK deﬁciency (Abarbanel et al. 1986; Wehner et al.
nt (lower arrow), indicating that they are heterozygous for the splice-site 1994). The high residual activity of PhK found in eryth-
mutation. The band of 20 nt cannot be detected by this method.
rocytes of the proband may be the result of the forma-
tion of a relatively instable but active agd complex. Chan
and Graves (1982) have shown that agd complexes arewere found in the region of the b gene that is not subject
to tissue-speciﬁc alternative splicing. Since two of these active in vitro. The formed agd complex might be more
stable in erythrocyte lysates than in liver homogenates,mutations, the 1827GrA (W609X) transition and the
IVS30-1,grt transversion, will lead either to the forma- so that in vitro activity of the mutated PhK is detectable
in erythrocyte lysate but not in liver homogenate. It istion of truncated b subunits or to the production of
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